L-methionine decreases dendritic spine density in mouse frontal cortex

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• Schizophrenia is linked to reduced gamma-aminobutyric acid and dendritic spine density in the brain.
• L-methionine exacerbates schizophrenia symptoms and has been shown to decrease reelin and GAD67 transcription.
• Valproate can prevent L-methionine-induced decreases in reelin and GAD67 transcription.

Purpose of the Study:

• To investigate the effect of L-methionine on dendritic spine density in mice.
• To determine if valproate can prevent L-methionine-induced changes in dendritic spine density.
• To explore the role of reelin in L-methionine-induced neurobiological alterations.

Main Methods:

• Administered L-methionine to mice to observe effects on brain structure.
• Co-administered valproate with L-methionine to assess protective effects.
• Quantified dendritic spine density in the frontal cortex of treated mice.

Main Results:

• L-methionine treatment led to a significant decrease in dendritic spine density.
• Co-administration of valproate prevented the reduction in dendritic spine density caused by L-methionine.
• These findings align with previous observations on reelin and GAD67 expression.

Conclusions:

• L-methionine-induced downregulation of dendritic spine density may be mediated by decreased reelin expression.
• Valproate may protect against spine loss by inhibiting methylation-induced decreases in reelin.
• These findings suggest a potential therapeutic role for valproate in conditions involving L-methionine-induced neurotoxicity.